- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03119870
Organization of the Cingulate Cortex (EEG-Feedback)
6 juli 2017 uppdaterad av: Hospices Civils de Lyon
Structure-function Relationships Within the Cingulate Cortex
Efficient evaluation and monitoring of actions and outcomes are a key feature of primates' efficient adaptive cognition.
Deficits in evaluating one's own actions and their consequences is a key feature of prominent disorders such as obsessive compulsive disorders (OCD), schizophrenia, and anxiety.
The Investigators know that these evaluative processes implicate medial structures of the brain that are related both to old limbic functions and to more recently evolved higher executive functions.
Brain potentials related to performance monitoring have attracted a lot of interest in cognitive neuroscience but also in the clinical domain because they appear to be altered in different neurological or psychiatric disorders, such as schizophrenia, OCD, or anxiety, and could become biomarkers of pathologies.
But the neural sources of these markers are not fully determined and are currently highly debated.
In addition, our work suggests that non pathological factors, such as normal morphological cortical variations, could affect those markers.
Understanding performance monitoring, acting directly on medial cortex, or using electrophysiological markers in clinic are thus currently problematic and challenging.
This is mostly because structure-function relationships in the medial wall are ill defined for historical, conceptual, and methodological reasons.
Importantly, although individual variability of brain morphology impedes precise assessment of structure function relationships, this variability is almost never taken into account.
EEG-Feedback aims to resolve these issues by evaluating the consequences of individual variability in cingulate cortex morphology on 1) surface EEG markers of feedback monitoring and 2) functional connectivity patterns thanks to resting-state fMRI.
Studieöversikt
Studietyp
Interventionell
Inskrivning (Faktisk)
31
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Bron, Frankrike, 69677
- Hospices Civils de Lyon, Groupement Hospitalier Est
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 40 år (Vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- being able to provide a writen consent form
- having a social insurance
- have a normal vision (with or without corrections)
- Right-handed
Exclusion Criteria:
- Subjects with MRI contraindications (e.g. pacemaker, claustrophobia, metal in the body, etc…).
- Subjects must be willing to be advise in case of discovery of brain abnormality.
- No history of known neurological or psychiatric illness
- Pregnant or nursing women
- Persons under guardianship, curatorship or any other administrative or judicial measure of deprivation of rights or liberty, as well as legal persons protected by law
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: 1
Each subject will conduct 3 sessions, i.e. a training session, an anatomical MRI session and an EEG session.
The first session will be to train the subject to carry out the different behavioral tasks that he will then have to perform during the session of EEG.
|
Each subject will be trained to perform a trial-error learning task.
In this task, three visual stimuli will be presented to the subject.
The subject will have to find by trial-error, the one associated with positive feedback, the other stimuli being associated with negative feedback (search period).
Once the stimulus is associated with positive feedback, the subject will perform a period of repetition during which he will choose the stimulus associated with positive feedback.
Two variants of the task will be used: a variant in which feedback will be visual (ie positive feedback = green square, negative feedback = red square) and a variant in which feedback will be fruit juice (ie positive feedback = Fruit juice (but less than 2ml), negative feedback = no volume or small volume of fruit juice).
Once the tasks are learned, each subject will participate in an MRI session during which an anatomical scan will be obtained.
For each task, the time of presentation of the stimuli will be 2s.
During this time, the subject should indicate his choice of stimulus.
After a delay of 2s, feedback will be presented for 1s.
Each test shall be separated by an inter-test delay of 3s.
The presentation of the stimuli and the control of the answers will be managed by the E-prime or Presentation software.
Once the tasks are learned, each subject will participate in an MRI session during which an anatomical scan will be obtained and then an EEG session during which he will perform the task learned.For each task, the time of presentation of the stimuli will be 2s.
During this time, the subject should indicate his choice of stimulus.
After a delay of 2s, feedback will be presented for 1s.
Each test shall be separated by an inter-test delay of 3s.
The presentation of the stimuli and the control of the answers will be managed by the E-prime or Presentation software.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Resting state fMRI data
Tidsram: 3 years
|
BOLD signal will be analyzed in the low frequency band (0.1-0.01Hz).
Images must be not too much distorted to allow data analysis.
As such, if a subject moved too much (translation>10mm; rotation>5°) the corresponding data will be excluded from the analysis.
|
3 years
|
|
EEG data
Tidsram: 3 years
|
If recordings are too noisy (if only <30% of trials survive the denoising process), subject will be excluded from final analysis.
|
3 years
|
|
Behavioral data in the EEG experiment
Tidsram: 3 years
|
Performance in the task will be assessed.
If performance in the task is <80%, subjects will be excluded in the final analysis.
|
3 years
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Huvudutredare: Christian SCHEIBER, MD, Hospices Civils de Lyon
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
9 januari 2013
Primärt slutförande (Faktisk)
6 september 2013
Avslutad studie (Faktisk)
4 juli 2017
Studieregistreringsdatum
Först inskickad
9 mars 2017
Först inskickad som uppfyllde QC-kriterierna
13 april 2017
Första postat (Faktisk)
19 april 2017
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
11 juli 2017
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
6 juli 2017
Senast verifierad
1 juli 2017
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- 69HCL16_0659
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .